Table 2.
Baseline criteria for female ME/CFS patients.
| Group 1 Severe (n = 20) | Group 2 Moderate (n = 31) | Group 3 Mild (n = 31) | ANOVA/Kruskal-Wallis Test | |
|---|---|---|---|---|
| Age (years) | 39 (10) | 41 (10) | 42 (9) | F (2, 79) = 0.46; p = 0.63 |
| Height (cm) | 171 (7) | 171 (7) | 169 (6) | F (2, 79) = 1.56; p = 0.22 |
| Weight (kg) | 70 (61–77) | 69 (63–80) | 65 (60–72) | X2(2) = 1.144; p = 0.56 |
| BSA (m2) | 1.4 (1.2–1.8) | 1.4 (1.3–1.5) | 1.3 (1.2–1.4) | X2(2) = 1.690; p = 0.43 |
| BMI (kg/m2) | 22.7 (21.8–27.6) | 23.9 (20.7–27.6) | 23.4 (21.4–26.7) | X2(2) = 0.032; p = 0.98 |
| Disease duration (years) | 15.9 (9.3) | 13.3 (8.9) | 13.5 (9.3) | F (2, 79) = 0.56; p = 0.57 |
Data are presented as mean (SD) or median (IQR). BMI: body mass index (DuBois formula); BSA: body surface area.